I’m hoping we already have a partner waiting in the wings, reliant on the p2a/b results. A partner from an endemic country, I’m thinking Singapore or Brazil. A company with experience in running the trial that’ll be needed and large enough to produce and distribute isla101 once it’s been approved. There’s no way we can do this on our own for such a large potential market and complicated P3 trial. The sooner we partner up the better.
As far as Gal is concerned im thinking once we are a phase 3 company with a commercial partner, we will be able to raise funds with a lot less dilution to get Gal through to registration and I think it’s been suggested we could possibly distribute on our own as we won’t be selling to the general public, just governments/militaries. So by 2027 we could have one approved drug that we are in the process of selling to governments around the world and another that has a huge market potential and is deep into its P3.
we can but dream…… let’s just hope the results are good first hey!!
ILA Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)